| Literature DB >> 34926681 |
Hao Zeng1,2, Yingfang Liang3, Jiaguo He4, Liyi Chen1, Haixia Su5, Simi Liao6, Sichun Huang1, Hongyu Qin1,2.
Abstract
Spinal tuberculosis (STB), which accounts for half of musculoskeletal tuberculosis, is among the leading causes of extrapulmonary tuberculosis. Guangxi Province, located in southern China, is among the most severely affected provinces in China. In this study, we collected and analyzed data from 2 Class-A tertiary teaching hospitals in Nanning City, Guangxi Province, from 2011 to 2019, with the aim of providing reference points for the prevention, diagnosis, treatment, and prognosis analysis of STB, using the epidemiological characteristics of 556 STB cases. Our results revealed that males had a slightly higher incidence (50.17%) compared to females (49.83%), with 64.93% of cases falling between the ages of 18 and 45 years. Cases from rural communities accounted for 63.49% of the reviewed cases. The average time between onset of symptoms and hospitalization was 18.0 months (range: 1 day-220 months). The most commonly reported symptoms were lower back pain (78.60%), radicular pain (51.98%), and systemic toxemia (43.53%). Additionally, 53.98% of the reviewed cases had varying degrees of neurological impairment. The main pathological lesion locations were the lumbar spine (43.53%) and thoracic spine (32.55%). Among them, 72.66% of cases involved at least 2 vertebral segments, and 62.77% of cases presented with paravertebral abscesses. Among the cases reviewed, 90.65% underwent antituberculosis chemotherapy prior to surgery. Following treatment, the cure rate was 78.41%, while 3.78% of patients had postoperative relapse. There were cases of concomitant illnesses among the cases reviewed, 40.65% of patients also had pulmonary tuberculosis, 15.29% had hepatitis B, 13.30% had diabetes, and 7.91% had hypertension. Our results still demonstrate that spinal tuberculosis remains a serious public health problem in Guangxi Province. Thus, preventive measures should be directed towards rural residents with comorbidities such as the elderly and diabetic.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34926681 PMCID: PMC8683179 DOI: 10.1155/2021/1344496
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Demographics and epidemiology of inpatients with STB.
| Year | Age (years) | Gender | Residence | Occupation | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <18 | 18~45 | 46~60 | >60 | Male | Female | Rural | Urban | Farmer | Worker | Student | Others | ||
| 2011 | 3 | 29 | 18 | 10 | 31 | 29 | 40 | 20 | 28 | 13 | 2 | 17 | 60 |
| 2012 | 3 | 25 | 8 | 4 | 21 | 19 | 26 | 14 | 22 | 5 | 1 | 12 | 40 |
| 2013 | 2 | 21 | 10 | 6 | 23 | 16 | 23 | 16 | 19 | 6 | 2 | 12 | 39 |
| 2014 | 2 | 17 | 7 | 4 | 17 | 13 | 17 | 13 | 15 | 4 | 1 | 10 | 30 |
| 2015 | 3 | 24 | 6 | 5 | 25 | 13 | 25 | 13 | 20 | 5 | 2 | 11 | 38 |
| 2016 | 7 | 51 | 11 | 7 | 31 | 45 | 45 | 31 | 55 | 10 | 5 | 6 | 76 |
| 2017 | 9 | 77 | 15 | 11 | 54 | 58 | 78 | 34 | 75 | 20 | 5 | 12 | 112 |
| 2018 | 6 | 59 | 12 | 8 | 36 | 49 | 50 | 35 | 54 | 12 | 6 | 13 | 85 |
| 2019 | 4 | 58 | 11 | 3 | 41 | 35 | 49 | 27 | 50 | 14 | 2 | 10 | 76 |
| Total | 39 | 361 | 98 | 58 | 279 | 277 | 353 | 203 | 338 | 89 | 26 | 103 | 556 |
| Rate (%) | 7.01 | 64.93 | 17.63 | 10.43 | 50.17 | 49.83 | 63.48 | 36.51 | 60.79 | 16.01 | 4.68 | 18.53 | |
|
| 46.929 | 10.923 | 4.593 | 37.833 | |||||||||
|
| 0.003 | 0.206 | 0.800 | 0.036 | |||||||||
Figure 1The geographical location and the number of patients in the main cities of Guangxi. (a) The number of STB patients in major cities. Nanning 17.09%, Guigang 15.83%, Chongzuo 12.95%, Wuzhou 9.17%, Yulin 6.47%, Laibin 6.29%, Baise 6.29%, Guilin 5.94%, Liuzhou 3.78%, Hechi 3.78%, Beihai 3.78%, Hezhou 3.24%, Qinzhou 2.88%, and Fangchenggang 2.51%. (b) The geographical location of major cities: Nanning (A), Guigang (B), Chongzuo (C), Wuzhou (D), Yulin (E), Laibin (F), Baise (G), Guilin (H), Liuzhou (I), Hechi (J), Beihai (K), Hezhou (L), Qinzhou (M), and Fangchenggang (N).
Clinical manifestations of patients with STB.
| Year | Clinical presentation | Neurological injury (Frankel classification) | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Back pain | Radiating pain | Systemic toxicity symptoms | ||||||||||
| Yes | No | Yes | No | Yes | No | A | B | C | D | E | ||
| 2011 | 45 | 15 | 34 | 26 | 25 | 35 | 2 | 1 | 4 | 20 | 33 | 60 |
| 2012 | 31 | 9 | 26 | 14 | 19 | 21 | 1 | 3 | 5 | 13 | 18 | 40 |
| 2013 | 29 | 10 | 17 | 12 | 16 | 23 | 3 | 4 | 4 | 12 | 16 | 39 |
| 2014 | 19 | 11 | 15 | 15 | 17 | 13 | 1 | 2 | 5 | 9 | 13 | 30 |
| 2015 | 31 | 7 | 13 | 25 | 13 | 25 | 1 | 1 | 4 | 15 | 17 | 38 |
| 2016 | 63 | 13 | 54 | 22 | 30 | 46 | 1 | 2 | 6 | 22 | 45 | 76 |
| 2017 | 93 | 19 | 53 | 59 | 59 | 53 | 3 | 5 | 12 | 42 | 50 | 112 |
| 2018 | 65 | 20 | 42 | 43 | 38 | 47 | 1 | 3 | 7 | 39 | 35 | 85 |
| 2019 | 61 | 15 | 35 | 41 | 25 | 51 | 2 | 4 | 9 | 32 | 29 | 76 |
| Total | 437 | 119 | 289 | 257 | 242 | 314 | 15 | 25 | 56 | 204 | 256 | 556 |
| Rate (%) | 78.60 | 21.40 | 51.98 | 48.02 | 43.53 | 56.47 | 2.70 | 4.50 | 10.07 | 36.69 | 46.04 | |
|
| 7.762 | 21.798 | 11.757 | 23.440 | ||||||||
|
| 0.457 | 0.005 | 0.162 | 0.864 | ||||||||
Imaging findings of patients with STB.
| Year | Lesion sites | Involved number of vertebrae | Abscess | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C | CT | T | TL | L | LS | S | 1 | 2 | ≥3 | Yes | No | ||
| 2011 | 2 | 8 | 18 | 5 | 21 | 2 | 4 | 7 | 41 | 12 | 39 | 21 | 60 |
| 2012 | 2 | 4 | 10 | 4 | 15 | 2 | 3 | 6 | 25 | 9 | 23 | 17 | 40 |
| 2013 | 1 | 2 | 10 | 4 | 17 | 2 | 3 | 4 | 23 | 12 | 26 | 13 | 39 |
| 2014 | 1 | 1 | 8 | 3 | 14 | 2 | 1 | 5 | 21 | 4 | 21 | 9 | 30 |
| 2015 | 2 | 3 | 12 | 3 | 14 | 2 | 2 | 6 | 27 | 5 | 24 | 14 | 38 |
| 2016 | 1 | 2 | 27 | 4 | 37 | 2 | 3 | 7 | 57 | 12 | 48 | 28 | 76 |
| 2017 | 3 | 8 | 39 | 7 | 49 | 4 | 2 | 8 | 92 | 12 | 76 | 36 | 112 |
| 2018 | 2 | 3 | 30 | 4 | 42 | 2 | 2 | 9 | 65 | 11 | 49 | 36 | 85 |
| 2019 | 2 | 4 | 27 | 3 | 33 | 4 | 3 | 7 | 53 | 16 | 43 | 33 | 76 |
| Total | 16 | 35 | 181 | 37 | 242 | 22 | 23 | 59 | 404 | 93 | 349 | 207 | 556 |
| Rate (%) | 2.88 | 6.29 | 32.55 | 6.65 | 43.53 | 3.96 | 4.14 | 10.61 | 72.66 | 16.73 | 62.77 | 37.23 | |
|
| 27.850 | 17.354 | 4.976 | ||||||||||
|
| 0.991 | 0.363 | 0.760 | ||||||||||
C: cervical; CT: cervicothoracic; T: thoracic; TL: thoracolumbar; L: lumbar; LS: lumbosacral; S: sacrococcygeal.
Treatment and prognosis of patients with STB.
| Year | Treatment | Prognosis | Total | |||
|---|---|---|---|---|---|---|
| Only anti-TB chemotherapy | Anti-TB chemotherapy and surgery | Cured | Relapse | Others | ||
| 2011 | 6 | 54 | 56 | 3 | 1 | 60 |
| 2012 | 5 | 35 | 35 | 2 | 3 | 40 |
| 2013 | 7 | 32 | 34 | 3 | 2 | 39 |
| 2014 | 3 | 27 | 25 | 1 | 4 | 30 |
| 2015 | 4 | 34 | 37 | 0 | 1 | 38 |
| 2016 | 6 | 70 | 62 | 4 | 10 | 76 |
| 2017 | 11 | 101 | 98 | 3 | 11 | 112 |
| 2018 | 6 | 79 | 75 | 3 | 8 | 85 |
| 2019 | 4 | 72 | 64 | 2 | 9 | 76 |
| Total | 52 | 504 | 486 | 21 | 49 | 556 |
| Rate (%) | 9.35 | 90.65 | 78.41 | 3.78 | 8.81 | |
|
| 5.835 | 17.847 | ||||
|
| 0.666 | 0.333 | ||||
Figure 2A 68-year-old male with T5/6 lesions. (a–f) The preoperative imaging data showed T5/6 vertebral bodies' destructions with kyphosis deformity and spinal cord severely compressed. The postoperative sagittal and coronal X-ray (g, h) indicated that the kyphosis got obviously improved.
Figure 3Comorbidities. (a) The number of patients with concomitant PTB. (b) The number of patients with concomitant hepatitis B. (c) The number of patients with concomitant diabetes. (d) The number of patients with concomitant hypertension.
Correlation analysis between STB and PTB.
| Variate | Type | With PTB | Without PTB | Total |
|
| ||
|---|---|---|---|---|---|---|---|---|
|
| % |
| % | |||||
| Gender | Male | 146 | 64.60 | 133 | 40.30 | 279 | 31.680 | <0.001 |
| Female | 80 | 35.4 | 197 | 59.7 | 277 | |||
| Systemic toxicity symptoms | Yes | 91 | 40.71 | 151 | 45.76 | 242 | 1.646 | 0.200 |
| No | 135 | 59.29 | 179 | 54.24 | 314 | |||
| Abscess | Yes | 158 | 69.91 | 131 | 39.70 | 349 | 49.059 | <0.001 |
| No | 68 | 30.09 | 199 | 60.3 | 207 | |||
| Neurological injury | Yes | 171 | 75.66 | 129 | 39.09 | 300 | 72.219 | <0.001 |
| No | 55 | 24.34 | 201 | 60.91 | 256 | |||
| Surgery | Yes | 196 | 86.73 | 308 | 93.33 | 504 | 6.908 | 0.009 |
| No | 30 | 13.27 | 22 | 6.67 | 52 | |||
| Prognosis | Cure | 186 | 82.30 | 300 | 90.90 | 486 | 9.032 | 0.003 |
| Other | 40 | 17.7 | 30 | 9.1 | 70 | |||
Correlation analysis between STB and diabetes.
| Variate | Type | With diabetes | Without diabetes | Total |
|
| ||
|---|---|---|---|---|---|---|---|---|
|
| % |
| % | |||||
| Age (years) | >45 | 61 | 82.43 | 95 | 19.71 | 156 | 125.032 | <0.001 |
| <45 | 13 | 17.57 | 387 | 80.29 | 400 | |||
| Systemic toxicity symptoms | Yes | 32 | 43.24 | 210 | 43.56 | 242 | 0.003 | 0.958 |
| No | 42 | 56.76 | 272 | 56.44 | 314 | |||
| Abscess | Yes | 53 | 71.62 | 296 | 61.41 | 349 | 2.862 | 0.091 |
| No | 21 | 28.38 | 186 | 38.59 | 207 | |||
| Neurological injury | Yes | 39 | 52.70 | 261 | 54.15 | 300 | 0.054 | 0.816 |
| No | 35 | 47.3 | 221 | 45.85 | 256 | |||
| Surgery | Yes | 36 | 48.64 | 468 | 97.1 | 504 | 177.603 | <0.001 |
| No | 38 | 51.36 | 14 | 2.90 | 52 | |||
| Prognosis | Cure | 58 | 78.37 | 428 | 88.79 | 486 | 6.327 | 0.012 |
| Other | 16 | 21.63 | 54 | 11.21 | 70 | |||